Pharmaceutical

SBTi approves Piramal Pharma’s GHG reduction targets

The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.

Sep 18, 2024 - 04:00
SBTi approves Piramal Pharma’s GHG reduction targets
The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.
Read the original article

Tags:

Previous Article

Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants

Next Article

Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bayer, short on cash, reaches into shareholders’ pockets

Bayer, short on cash, reaches into shareholders’ pockets

Feb 21, 2024

STAT+: Using its Covid know-how, Color Health aims to make cancer screenings convenient

STAT+: Using its Covid know-how, Color Health aims to m...

Jun 24, 2023

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi approval

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi a...

Apr 3, 2023